Fujitsu and Osaka University Move Chemical Calculations to Early Fault-Tolerant Quantum Computers

Fujitsu and Osaka University Move Chemical Calculations to Early Fault-Tolerant Quantum Computers

Quantum Leap: Fujitsu and Osaka University Unlock Practical Chemical Calculations

Current quantum hardware struggles with the scale and error rates required for reliable chemical and material simulations. A joint effort by Fujitsu and the University of Osaka reports a practical advance: two complementary technologies that bring complex energy calculations within reach of early fault-tolerant quantum computers (early-FTQC). Their work points toward real-world uses in drug discovery, materials development, and energy research.

Dual Innovation: STAR Architecture Version 3 and Model Optimization

The first pillar is STAR Architecture Version 3, which reforms how quantum circuits represent molecular systems to lower qubit demand and relax error-rate requirements. The second is Molecular Model Optimization Technology, a suite of algorithmic reductions that streamline molecular representations and minimize computational overhead and run time. Together these methods reduce the resource burden while preserving chemical accuracy.

Accelerating Real-World Discovery

The team validated their approach on challenging systems including Cytochrome P450 and iron-sulfur clusters. Key results are striking: qubit requirements fall by factors between 1/15 and 1/80, error tolerance is relaxed to about 0.10%, and projected computation times drop from effectively millennia to days for comparable classical-quantum workflows. These gains make accurate energy estimates for larger molecules practically attainable on near-term, error-corrected machines.

The Path to Accessible Quantum Computing

This milestone does not complete the road to universal, large-scale quantum advantage, but it shortens several critical gaps. Continued refinement of STAR v3 and molecular optimizations, plus integration with hardware roadmaps, will broaden application scope and shorten commercialization timelines. For business leaders and investors, the outcome is a clearer pathway: earlier, targeted deployments in drug discovery, new material development, energy system modeling, and high-value computational finance use cases.

Fujitsu and Osaka University have produced a concrete step toward turning early-FTQC from experimental promise into a practical toolset for industry-focused quantum chemistry.